Sec. 3. Authorization for United States participation
244 words·~1 min read·
/bill/116/hr/6334/ih/section-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The United States is hereby authorized to participate in the Coalition for Epidemic Preparedness Innovations. The Coalition for Epidemic Preparedness Innovations shall be considered a public international organization for purposes of section 1 of the International Organizations Immunities Act ( 22 U.S.C. 288 ). Not later than 180 days after the date of the enactment of this Act, the President shall submit to the appropriate congressional committees a report that includes the following:
The United States planned contributions to the Coalition for Epidemic Preparedness Innovations and the mechanisms for United States participation in such Coalition. The manner and extent to which the United States shall participate in the governance of the Coalition. How participation in the Coalition supports relevant United States Government strategies and programs in health security and biodefense, to include— the Global Health Security Strategy required by section 7058(c)(3) of division K of the Consolidated Appropriations Act, 2018 ( Public Law 115–141 ); the applicable revision of the National Biodefense Strategy required by section 1086 of the National Defense Authorization Act for Fiscal Year 2017 ( 6 U.S.C. 104 ); and any other relevant decision-making process for policy, planning, and spending in global health security, biodefense, or vaccine and medical countermeasures research and development.
In this section, the term appropriate congressional committees means— the Committee on Foreign Affairs and the Committee on Appropriations of the House of Representatives; and the Committee on Foreign Relations and the Committee on Appropriations of the Senate.
Connectionstraces to 3
Traces to 3 documents
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources